Jones Financial Companies
AYTU icon

Jones Financial Companies’s AYTU BioPharma AYTU Stock Holding History

Jones Financial Companies’s Portfolio AYTU Stock Details AYTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3 Hold
1
– – ﹤0.01% 4715
2025
Q4 		$3 Hold
1
– – ﹤0.01% 4387
2025
Q3 		$2 Hold
1
– – ﹤0.01% 4221
2025
Q2 		$2 Sell
1
-11
-92% -$17 ﹤0.01% 4025
2025
Q1 		$15 Buy
+12
New +$17 ﹤0.01% 3684

Other funds holding AYTU

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $588M AUM 182.75% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CAM
Crown Advisors Management Larkspur, California $151M AUM 73.11% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PAP
Persistent Asset Partners Hong Kong $268M AUM 158.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jones Financial Companies's AYTU Position: Q1 2026 in Review

Jones Financial Companies held its AYTU BioPharma (AYTU) position steady in Q1 2026 at 1 share worth $3. The position accounts for ﹤0.01% of the portfolio, ranked #4715.

Jones Financial Companies first reported a position in AYTU in Q1 2025 and has held it in 5 quarters since. The position peaked at $15 in Q1 2025. 37 funds tracked by Wall St. Rank hold AYTU as of Q1 2026.

  • Jones Financial Companies held 1 share of AYTU BioPharma worth $3 as of Q1 2026.
  • Jones Financial Companies left its AYTU BioPharma share count unchanged in Q1 2026.
  • AYTU BioPharma made up ﹤0.01% of Jones Financial Companies's portfolio in Q1 2026, its #4715 holding.
  • Jones Financial Companies first reported a position in AYTU BioPharma in Q1 2025 and has held it in 5 quarters since.
  • Jones Financial Companies's AYTU BioPharma position peaked at $15 in Q1 2025.
  • 37 funds tracked by Wall St. Rank held AYTU BioPharma as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.